NexgenRx Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was CAD 11.041 million compared to CAD 9.539 million a year ago. Net income was CAD 2.115 million compared to net loss of CAD 207,935 a year ago. Basic earnings per share from continuing operations was CAD 0.03 compared to basic loss per share from continuing operations of CAD 0.003 a year ago.